Earnings release · ZBH
Zimmer Biomet Announces
Zimmer Biomet Holdings, Inc. · Filed · SEC Form 8-K, Item 2.02
Zimmer Biomet Holdings, Inc. company page Original on SEC.gov ↗
Why it matters
Revenue rose 4.8% year on year to $2.177 billion, and EPS grew 33.8% to $1.03. Growth in both sales and earnings is the combination investors usually look for first. Management raised its outlook, and guidance changes often matter more to the market than the quarter just reported because they reflect expectations for the periods ahead.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
$2.177 billion +4.8% vs a year ago
…Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0%…
$1.03 +33.8% vs a year ago
…Second quarter diluted earnings per share were $1.03, an increase of 33.8%; adjusted1 diluted earnings per share were $2.07, consistent with the…
Guidance raised
…t changes progressing as planned and continued momentum from our innovation cycle, we are raising our revenue and adjusted EPS guidance for the year. | Announced increase to share repurchase expectations of up to $1 billion of its common stock during fiscal year 2026.…